Browse the shelves of any Japanese drugstore or beauty boutique, and you will quickly notice English words like "Medicated" stamped prominently across lotions, milky emulsions, and cleansers. On the packaging reverse, these products feature the Japanese term iyakubugaihin (quasi-drug) rather than standard cosmetic labeling. For international shoppers accustomed to Western or Korean regulatory frameworks, this classification often causes confusion. Does "medicated" mean the product requires a doctor prescription, or is it merely clever advertising?

Quick answer:

What is a quasi-drug (medicated cosmetic) in Japan?

In Japan, a **quasi-drug** (*iyakubugaihin*, often marketed as *yakuyou* or "medicated") occupies a unique regulatory middle ground between general cosmetics and pharmaceutical medicines under Japan's Pharmaceutical and Medical Devices Act (PMD Act). Quasi-drugs contain government-approved **active ingredients** (*yuukou seibun*) at clinically evaluated percentages designed to **prevent** specific skin concerns—such as rough texture, acne, or sun-induced dark spots. Unlike prescription drugs intended for clinical disease resolution, Japanese quasi-drugs offer mild, over-the-counter physiological action focused strictly on daily prevention.

Japanese quasi drug skincare bottles formulated with government approved active ingredients

The Tripartite System: Cosmetics vs Quasi-Drugs vs Pharmaceuticals

Conclusion: Japan classifies skincare into three tiers: General Cosmetics for surface hydration, Quasi-Drugs for government-approved prevention, and Pharmaceuticals for medical intervention.
Assortment of Japanese cosmetic and medicated skincare bottles illustrating regulatory categories

To appreciate how Japanese skincare operates, one must understand the three-tier framework established by Japan's Ministry of Health, Labour and Welfare (MHLW) under the PMD Act:

1. General Cosmetics (Keshohin)

General cosmetics include ordinary moisturizers, cleansing oils, and lip balms. Their regulatory objective is strictly limited to cleaning, beautifying, and maintaining the surface moisture of the epidermis. Brands cannot claim specific physiological changes, and formulations do not require pre-market government verification of therapeutic active percentages.

2. Quasi-Drugs (Iyakubugaihin / Yakuyou)

Quasi-drugs represent an intermediate category with mild physiological effects. To qualify, a manufacturer must formulate recognized active ingredients within defined concentration thresholds and submit clinical data to the regulatory authorities. These products are permitted to advertise specific government-authorized preventative benefits, such as preventing rough skin, calming redness, or suppressing melanin synthesis.

3. Pharmaceuticals (Iyakuhin)

Pharmaceuticals are therapeutic medications prescribed by physicians or dispensed by licensed pharmacists. Their primary role is to manage, mitigate, or resolve diagnosed dermatological illnesses—such as severe atopic dermatitis, bacterial acne infections, or psoriasis. They carry potent biological activity and higher risks of adverse side effects.


What Makes a Cosmetic "Medicated" (Yakuyou): Active Ingredients

Conclusion: The term "medicated" legally requires formal quasi-drug approval and the inclusion of verified active ingredients like tranexamic acid or dipotassium glycyrrhizate.
Medicated Japanese skincare regimen bottles placed neatly on an elegant marble surface

In Japanese marketing, the word yakuyou (literally "medicinal use") is legally synonymous with quasi-drug (iyakubugaihin). A cosmetic cannot use the word "medicated" on its packaging unless it has received formal quasi-drug authorization.

The defining characteristic of a Japanese quasi-drug is the presence of one or more approved Active Ingredients (yuukou seibun):

  • Dipotassium Glycyrrhizate & Stearyl Glycyrrhetinate: Licorice-root derivatives approved for preventing skin roughness, razor irritation, and flaking.
  • Tranexamic Acid: An amino acid derivative authorized for suppressing melanin synthesis and preventing sun spots (shimi) and freckles.
  • Niacinamide (Nicotinamide): Approved for brightening benefits and, in higher regulated percentages, improving the appearance of fine wrinkles while supporting skin barrier moisture.
  • Isopropyl Methylphenol (o-Cymen-5-ol): An antimicrobial agent authorized for purifying acne-prone skin and preventing blemish formation.
  • L-Ascorbic Acid 2-Glucoside: A stable vitamin C derivative approved for antioxidant protection and dark spot prevention.

Crucially, Japanese quasi-drugs display their ingredient lists differently from general cosmetics. On standard cosmetics, ingredients must follow international INCI rules, appearing in strict descending order of concentration. On quasi-drugs, however, the label splits ingredients into Active Ingredients (yuukou seibun) listed first, followed by Other Ingredients (sono ta no seibun). The "other ingredients" are not legally required to follow descending order, which is why Japanese quasi-drug ingredient lists often look distinct on imported packaging.


Approved Efficacy Claims: Prevention vs Clinical Care

Conclusion: Japanese quasi-drugs are strictly restricted to preventative claims rather than curative claims, targeting daily maintenance before medical issues develop.

A foundational principle of Japanese cosmetics law is the strict divide between prevention (yobou) and medical resolution (chiryou):

Quasi-drugs are legally authorized only for preventative claims. For example, a medicated acne face wash may claim to "cleanse skin and prevent pimples," but it cannot claim to "resolve existing cystic acne." Similarly, a medicated brightening lotion may claim to "suppress melanin generation and prevent dark spots caused by sun exposure," but it cannot claim to "remove existing deep hyperpigmentation."

Scroll horizontally to view the full comparison.

Feature General Cosmetic (*Keshohin*) Quasi-Drug (*Iyakubugaihin*) Pharmaceutical (*Iyakuhin*)
Regulatory Tier Cosmetic oversight Intermediate government approval Medical drug regulation
Active Ingredient Disclosure Single descending INCI list Separated active vs other ingredients Exact pharmaceutical dosage
Authorized Scope Moisturizing & cleansing surface Preventing roughness, spots, & acne Managing clinical medical disease
Availability Everywhere over the counter Over the counter (drugstores, shops) Pharmacies & doctor prescription
Primary Purpose Daily hydration & skin aesthetic Targeted daily barrier prevention Clinical dermatological intervention